Insider Shareholders with Direct Ownership of Oncotelic Therapeutics, Inc. (OTLC)
This section provides a comprehensive overview of the insiders with direct ownership of Oncotelic Therapeutics, Inc. (OTLC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Oncotelic Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Vuong Trieu
CHAIRMAN AND CEO |
76,782,409 | 0 | 92,544,217 $2.78 Million | 14 |
Aug 23, 2024
Added 0.54%
|
|
Saran Saund
Chief Business Officer |
16,457,480 | 0 | 16,457,480 $493,724 | 2 |
Jul 08, 2021
Added 0.62%
|
|
Chulho Park
CHIEF TECHNOLOGY OFFICER |
22,173 | 0 | 2,833,992 $85,019 | 1 |
Nov 19, 2020
Added 0.78%
|
|
Anthony E Maida Iii
Chief Clin. Ops. Officer |
938,646 | 0 | 1,137,314 $34,119 | 1 |
Mar 31, 2021
Added 45.22%
|
|
Amit B. Shah
CHIEF FINANCIAL OFFICER |
358,837 | 0 | 358,837 $10,765 | 4 |
Jul 08, 2021
Added 45.44%
|